Found 4 results
Filters: Author is Jala, Venkatakrishna R [Clear All Filters]
2019
Singh R, Chandrashekharappa S, Bodduluri SR, Baby BV, Hegde B, Kotla NG, Hiwale AA, Saiyed T, Patel P, Vijay-Kumar M et al..
2019. Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway.. Nat Commun. 10(1):89.
Totiger TM, Srinivasan S, Jala VR, Lamichhane P, Dosch AR, Gaidarski AA, Joshi C, Rangappa S, Castellanos J, Vemula PKumar et al..
2019. Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer.. Mol Cancer Ther. 18(2):301-311.
2017
Singh R, Hegde B, Von Baby B, Sadeep C, Kotla N, Chandrasekar B, Marepally S, Bodduluri H, Vemula PK, Jala VR.
2017. Targeted delivery of microbial metabolite, urolithin A protects from chemically (DSS or TNBS) induced colitis in pre-clinical models. The Journal of Immunology. 198:65.6–65.6.
2016